
Research Specifications
- Sequence:
- Ac-Nle-cyclo(Asp-His-D-Phe-Arg-Trp-Lys)-OH
- CAS:
- 189691-06-3
- Molecular Weight:
- 1025.18 Da
- Vial:
- 10mg lyophilized
- Purity:
- ≥98% HPLC verified
PT-141 10mg
Bremelanotide cyclic heptapeptide
CAS: 189691-06-3
2019
FDA Vyleesi approval
AMAG Pharma
1.75 mg
Rx dose (Vyleesi)
Product label
~2 hr
Half-life
Clinical PK
Receptor Targets
MC4RPrimary target — central libido signaling
MC3RSecondary — satiety/autonomic modulation
MC1RWeak binding — minimal pigmentation effect
$62.99In Stock
Buy Now ≥98% Purity Verified Free Shipping $200+ HPLC Tested
Reconstitution & Dosing Guide
BAC Water
2mL
Final Concentration
5 mg/mL
Per Dose
1.75 mg = 0.35 mL (35 IU) · 1 mg = 0.2 mL (20 IU)
Administer 45 min–4 hours prior to intended effect window in research protocols
Published References
- 1.Kingsberg SA, Clayton AH, Portman D, et al.. Bremelanotide for the Treatment of Hypoactive Sexual Desire Disorder. Obstetrics & Gynecology (2019) PMID: 31599840
- 2.Safarinejad MR, Hosseini SY. Salvage of sildenafil failures with bremelanotide. Journal of Urology (2008) PMID: 18423695
Research Use Only. This product is intended for in-vitro laboratory research only. Not for human consumption, injection, or therapeutic use. Not medical advice. Always consult applicable regulations in your jurisdiction.
Price Comparison
| Supplier | Purity | Price | Shipping |
|---|---|---|---|
| our verified supplier | >98% HPLC | $62.99 | Free over $200 |
| Generic Research Suppliers | Varies (often <95%) | Similar–Higher | Varies |
| Pharmaceutical (Rx only) | Pharmaceutical grade | Not available for research | Rx required |
Buy Peptides Compounds

Oxytocin 10mg
$71.99Buy Now

Oxytocin 8mg
$62.99Buy Now
PT-141 10mg
$62.99

